Yazici et al. IA Lorecivivint in Knee OA. 56 week DB-RCT of single injection at time 0. Didn't work. Not for primary endpoint (Pain NRS) or any PRO. @RheumNow #ACR22 Abstr#1639 https://t.co/66KyJW1zVz
Links:
A Phase 3, 56-Week, Multicenter, Randomized, Double-Blind, Placebo Controlled T…
https://acrabstracts.org/abstract/a-phase-3-56-week-multicenter-randomized-doub…
Nov-14-2022
